ClinicalTrials.gov
public full text
Public Domain
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the prevention and management of chemotherapy-induced alopecia (CIA). Therefore, we hypothesize that PBMT can reduce the severity of CIA in gynecological and breast cancer patients, increasing the patient's QoL.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of Alopecia#1185146
- A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia#861057
- Gold-thiopurine and thioguanine platforms for chemotherapy and photodynamic therapy#978770
- Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas#892974
- Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis#1230294
Record · ID 1262339
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive